<DOC>
	<DOCNO>NCT02168868</DOCNO>
	<brief_summary>The purpose study analyze immunological profile blood child ASD .</brief_summary>
	<brief_title>Immune Tests Blood Samples From Children With ASD</brief_title>
	<detailed_description>There accumulate evidence least subset child diagnose ASD also aberrant immune function . This study attempt identify specifically nature potential immune abnormality child . The study follow case-control design . Only one blood drawing perform upon meet inclusion criterion complete questionnaire include detailed information regard family history immune aberration . Five ml venous blood drawn subject ( ASD control ) shall separate 2 vial : - 0.5 ml : Complete Blood Count - 4.5 ml serum separation . The serum aliquoted ( 0.5 ml vial ) freeze -80º centigrade send laboratory detail immune analysis . One aliquot send analysis . The others keep test ( ±backup ) . Adverse event blood draw report Data Coordinating Center use appropriate Case Report Form ( CRF ) . In case adverse effect ( AE ) relate draw blood performance examination patient course standard examination procedure , investigate team proceed accordance local guideline ( inserted PI ) , report incident occur course clinical trial . Clinical data collect investigator , person appoint appropriately trained investigator , shall enter standardized CRFs share online sponsor . Source data retain data enter CRFs . Progress report Final Report conclusion trial submit regulatory authority Ethics Committee , require .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Male female child age 212 Diagnosed autism spectrum disorder ( ASD ) accord Diagnostic Statistical Manual Mental Disorders ( DSM ) IV ( 299.00 ) DSMV ( 299.00 ) . Informed consent sign parent All child treat systemic steroid undergone immune suppression treatment last 6 month . All child diagnose severe infectious disease sepsis last 6 month . All child diagnose mild infectious disease ( include common cold , ear infection , etc . ) last month Children ASD treat severe convulsive disorder . Children hematological malignant disorder .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Child Development Disorders , Pervasive</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Risk Factors</keyword>
</DOC>